🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the maximum tolerated dose (MTD), as a percentage of calories ...
Status
Completed
Location
UT Southwestern Medical Center
Start Date
2017-03-29
Trial ID
NCT03041363
Treatments Being Tested
The purpose of the study is to determine if triheptanoin is an effective tr...
Status
Completed
Location
Department of Genetics, Groupe Hospitalier Pitié-Salpêtrière
Start Date
2009-06
Trial ID
NCT00947960
Treatments Being Tested
This is a medical research study to test a medication in patients with a di...
Status
Recruiting
Location
UPMC Children's Hospital of Pittsburgh
Start Date
2024-07-11
Trial ID
NCT06340685
Treatments Being Tested
The primary objective of the study was to evaluate the impact of UX007 on a...
Status
Completed
Location
Children's National Medical Center
Start Date
2014-02-06
Trial ID
NCT01886378
Treatments Being Tested
This study will be an open-label, prospective, interventional feasibility p...
Status
Completed
Location
Duke University Medical Center
Start Date
2020-10-16
Trial ID
NCT03665636
Treatments Being Tested
The purpose of this study is to determine whether triheptanoin (UX007) is e...
Status
No Longer Available
Location
Department of Neurology, Boston Children's Hospital
Start Date
TBD
Trial ID
NCT02500082
Treatments Being Tested
The purpose of this project is to study the efficacy of triheptanoin oil in...
Status
Completed
Location
Brain and Spine Institute
Start Date
2013-12-04
Trial ID
NCT02014883
Treatments Being Tested
Humans eat long-chain fat in their diet and use it for energy during exerci...
Status
Completed
Location
Oregon Health & Science University
Start Date
2011-09
Trial ID
NCT01379625
Treatments Being Tested
The aim of this study is to evaluate the safety and tolerability of trihept...
Status
Unknown
Location
Center for Rare Neurological Diseases
Start Date
2016-06
Trial ID
NCT02696044
Treatments Being Tested
Study design: Parallel group, placebo-controlled, dose-escalation each 2 mo...
Status
Completed
Location
Queensland Children's Hospital
Start Date
2022-03-15
Trial ID
NCT04513002
Treatments Being Tested